10.3760/cma.j.issn.2096-5540.2018.03.013
Imiquimod-induced localized vitiligo-like hypopigmentation
Introduction Imiquimod is an immune response modifier,currently the 5% imiquimod cream is approved for treatment of extemal genital,perianal warts,superficial basal cell carcinoma,and actinic keratoses.Its anti-viral activity and anti-tumoral activity seem to be dependent on focal activation of the immune system with induction,synthesis,and release of cytokines,such as interferonalpha,interleukin-12 and tumor necrosis factor alpha”1-2”.
1
2018-10-29(万方平台首次上网日期,不代表论文的发表时间)
共4页
189-192